Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 4:01 PM View:  | 89bio, Inc. (ETNB) | 01-Apr-24 | Option Exercise | 25,000 | $1.93 | $48,250.00 | 5% 486.89K to 511.89K | |
| 03-Apr-24 4:01 PM View: | 89bio, Inc. (ETNB) | 01-Apr-24 | Planned Option Sale | 25,000 | $10.91 | $272,750.00 | (5%) 511.89K to 486.89K | |
| 03-Apr-24 4:01 PM View: | 89bio, Inc. (ETNB) | 01-Apr-24 | Sale (Planned) | 27,718 | $10.91 | $302,403.00 | (6%) 486.89K to 459.17K | |
| 28-Feb-24 6:43 PM View: | 89bio, Inc. (ETNB) | 26-Feb-24 | Sale (Planned) | 4,477 | $10.76 | $48,172.50 | (< 1%) 491.37K to 486.89K | |
| 23-Feb-24 8:51 PM View: | 89bio, Inc. (ETNB) | 17-Feb-24 | Payment of Exercise | 4,602 | $9.74 | $44,823.50 | (< 1%) 495.97K to 491.37K | |
| 13-Feb-24 8:58 PM View: | 89bio, Inc. (ETNB) | 09-Feb-24 | Payment of Exercise | 12,670 | $8.45 | $107,062.00 | (3%) 493.64K to 480.97K | |
| 05-Feb-24 8:16 PM View: | 89bio, Inc. (ETNB) | 05-Feb-24 | Payment of Exercise | 5,068 | $9.80 | $49,666.40 | (1%) 498.71K to 493.65K | |
| 05-Feb-24 8:16 PM View: | 89bio, Inc. (ETNB) | 01-Feb-24 | Grant | 150,000 | -- | -- | 43% 348.71K to 498.71K | |
| 08-Jan-24 6:31 PM View: | 89bio, Inc. (ETNB) | 05-Jan-24 | Grant | 75,000 | -- | -- | 25% 301.23K to 376.23K | |
| 08-Jan-24 6:31 PM View: | 89bio, Inc. (ETNB) | 05-Jan-24 | Payment of Exercise | 27,511 | $11.53 | $317,202.00 | (7%) 376.23K to 348.71K | |
| 03-Jan-24 4:54 PM View: | 89bio, Inc. (ETNB) | 29-Dec-23 | Option Exercise | 50,000 | $1.93 | $96,500.00 | 17% 301.23K to 351.23K | |
| 03-Jan-24 4:54 PM View: | 89bio, Inc. (ETNB) | 29-Dec-23 | Planned Option Sale | 50,000 | $11.20 | $560,000.00 | (14%) 351.23K to 301.23K | |
| 21-Aug-23 5:49 PM View: | 89bio, Inc. (ETNB) | 17-Aug-23 | Payment of Exercise | 4,501 | $15.46 | $69,585.50 | (1%) 305.45K to 300.95K | |
| 05-Jul-23 10:00 PM View: | 89bio, Inc. (ETNB) | 30-Jun-23 | Grant | 33,334 | -- | -- | 12% 288.64K to 321.98K | |
| 05-Jul-23 10:00 PM View: | 89bio, Inc. (ETNB) | 30-Jun-23 | Payment of Exercise | 16,527 | $18.95 | $313,187.00 | (5%) 321.98K to 305.45K | |
| 07-Jun-23 5:04 PM View: | 89bio, Inc. (ETNB) | 05-Jun-23 | Option Exercise | 15,000 | $1.93 | $28,950.00 | 5% 286.98K to 301.98K | |
| 07-Jun-23 5:04 PM View: | 89bio, Inc. (ETNB) | 05-Jun-23 | Option Sale | 15,000 | $20.00 | $300,000.00 | (5%) 301.98K to 286.98K | |
| 04-Apr-23 4:18 PM View: | 89bio, Inc. (ETNB) | 31-Mar-23 | Grant | 33,333 | -- | -- | 12% 269.08K to 302.41K | |
| 04-Apr-23 4:18 PM View: | 89bio, Inc. (ETNB) | 31-Mar-23 | Payment of Exercise | 15,443 | $15.23 | $235,197.00 | (5%) 302.41K to 286.97K | |
| 27-Mar-23 7:18 PM View: | 89bio, Inc. (ETNB) | 23-Mar-23 | Private Sale | 15,000 | $16.00 | $240,000.00 | (5%) 284.08K to 269.08K | |
| 22-Feb-23 6:38 PM View: | 89bio, Inc. (ETNB) | 17-Feb-23 | Payment of Exercise | 6,279 | $13.97 | $87,717.60 | (2%) 290.35K to 284.07K | 7% |
| 13-Feb-23 5:42 PM View: | 89bio, Inc. (ETNB) | 09-Feb-23 | Grant | 75,000 | -- | -- | 35% 215.35K to 290.35K | |
| 07-Feb-23 7:36 PM View: | 89bio, Inc. (ETNB) | 05-Feb-23 | Payment of Exercise | 4,078 | $13.24 | $53,992.70 | (2%) 219.43K to 215.35K | 2% |
| 30-Sep-22 7:02 PM View: | 89bio, Inc. (ETNB) | 28-Sep-22 | Grant | 33,333 | -- | -- | 17% 197.62K to 230.96K | |
| 30-Sep-22 7:02 PM View: | 89bio, Inc. (ETNB) | 28-Sep-22 | Payment of Exercise | 11,527 | $5.76 | $66,395.50 | (5%) 230.96K to 219.43K | |
| 09-Sep-22 4:39 PM View: | 89bio, Inc. (ETNB) | 08-Sep-22 | Option Exercise | 100,000 | $1.93 | $193,000.00 | 102% 97.62K to 197.62K | |
| 22-Feb-22 5:06 PM View: | 89bio, Inc. (ETNB) | 17-Feb-22 | Grant | 54,200 | -- | -- | 118% 45.84K to 100.05K | |
| 13-Apr-22 4:05 PM View: | 89bio, Inc. (ETNB) | 05-Feb-22 | Payment of Exercise | 4,088 | $5.23 | $21,380.20 | (4%) 100.05K to 95.96K | |
| 31-Jan-22 4:30 PM View: | 89bio, Inc. (ETNB) | 28-Jan-22 | Purchase | 2,500 | $6.14 | $15,350.00 | 6% 43.34K to 45.84K | |
| 31-Jan-22 4:30 PM View: | 89bio, Inc. (ETNB) | 27-Jan-22 | Private Purchase | 5,000 | $7.50 | $37,500.00 | 13% 38.34K to 43.34K | |
| 08-Jul-21 4:05 PM View: | 89bio, Inc. (ETNB) | 08-Jul-21 | Market Purchase | 2,000 | $16.25 | $32,500.00 | 6% 35.0K to 37.0K | 1% |
| 08-Jul-21 4:05 PM View: | 89bio, Inc. (ETNB) | 07-Jul-21 | Market Purchase | 5,000 | $17.07 | $85,350.00 | 17% 30.0K to 35.0K | (4%) |
| 09-Feb-21 4:55 PM View: | 89bio, Inc. (ETNB) | 05-Feb-21 | Grant | 30,000 | -- | -- | 100% 0 to 30.0K | |
| 28-Nov-14 9:00 PM View: | Avanir Pharmaceuticals (AVNR) | 28-Nov-14 | Market Sale (Planned) | 15,000 | $15.00 | $225,000.00 | (5%) 317.81K to 302.81K | (< 1%) |
| 12-Nov-14 10:00 PM View: | Avanir Pharmaceuticals (AVNR) | 10-Nov-14 | Grant | 94,056 | -- | -- | 42% 223.75K to 317.81K | |
| 17-Sep-14 8:28 PM View: | Avanir Pharmaceuticals (AVNR) | 15-Sep-14 | Market Sale (Planned) | 25,000 | $11.50 | $287,500.00 | (9%) 291.75K to 266.75K | < 1% |
| 14-Feb-14 7:54 PM View: | Avanir Pharmaceuticals (AVNR) | 12-Feb-14 | Grant | 123,750 | -- | -- | 87% 143.0K to 266.75K | |
| 19-Dec-13 4:31 PM View: | Avanir Pharmaceuticals (AVNR) | 17-Dec-13 | Market Purchase | 10,000 | $2.80 | $28,000.00 | 8% 133.0K to 143.0K | 307% |
| 05-Nov-13 8:01 PM View: | Avanir Pharmaceuticals (AVNR) | 04-Nov-13 | Market Purchase | 10,000 | $4.19 | $41,895.00 | 8% 123.0K to 133.0K | 172% |
| 19-Dec-12 4:41 PM View: | Avanir Pharmaceuticals (AVNR) | 17-Dec-12 | Grant | 63,000 | -- | -- | 105% 60.0K to 123.0K | |
| 17-Dec-12 4:15 PM View: | Avanir Pharmaceuticals (AVNR) | 13-Dec-12 | Market Purchase | 10,000 | $2.46 | $24,598.00 | 20% 50.0K to 60.0K | 363% |
| 02-Nov-12 9:00 PM View: | Avanir Pharmaceuticals (AVNR) | 03-Apr-12 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 21-Apr-11 10:00 PM View: | Medivation, Inc. (MDVN) | 20-Apr-11 | Option Exercise | 12,500 | $15.71 | $196,375.00 | 75% 16.67K to 29.17K | |
| 21-Apr-11 10:00 PM View: | Medivation, Inc. (MDVN) | 20-Apr-11 | Market Option Sale (Planned) | 12,500 | $22.63 | $282,825.00 | (43%) 29.17K to 16.67K | (620%) |
| 22-Mar-11 4:36 PM View: | Medivation, Inc. (MDVN) | 21-Mar-11 | Market Sale (Planned) | 7,500 | $16.05 | $120,375.00 | (31%) 24.17K to 16.67K | (915%) |
| 17-Dec-10 4:10 PM View: | Medivation, Inc. (MDVN) | 15-Dec-10 | Grant | 16,666 | -- | -- | 222% 7.5K to 24.17K | |
| 18-May-10 7:04 PM View: | Medivation, Inc. (MDVN) | 17-May-10 | Market Sale (Planned) | 2,500 | $10.91 | $27,270.00 | 50% 5.0K to 7.5K | 1426% |
| 03-Feb-10 1:33 PM View: | Medivation, Inc. (MDVN) | 01-Feb-10 | Option Exercise | 12,500 | $15.71 | $196,375.00 | 83% 15.0K to 27.5K | |
| 03-Feb-10 1:33 PM View: | Medivation, Inc. (MDVN) | 01-Feb-10 | Market Option Sale (Planned) | 12,500 | $33.59 | $419,875.00 | (45%) 27.5K to 15.0K | (396%) |
| 03-Feb-10 1:33 PM View: | Medivation, Inc. (MDVN) | 01-Feb-10 | Market Sale (Planned) | 5,000 | $33.59 | $167,950.00 | (33%) 15.0K to 10.0K | (396%) |